{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:03:40Z","timestamp":1779692620579,"version":"3.53.1"},"reference-count":45,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Vascular dementia (VaD) and mixed dementia (MD) represent prevalent causes of cognitive decline in the elderly, as they share similar pathological pathways and clinical features. Distinguishing between these two conditions remains a challenge, due to their frequent clinical and neuroimaging overlap. Nevertheless, it is important from a prognostic perspective. Materials and Methods: The study comprised 114 participants, including patients with VaD (n = 33), MD (n = 26), Alzheimer\u2019s disease (AD; n = 26), and 29 cognitively healthy controls (C). We evaluated routinely used cerebrospinal fluid (CSF) biomarkers (total tau, p-tau181, A\u03b21\u201342) and their ratios to assess inter-group differences, diagnostic accuracy, and correlations with cognitive score. Results: Patients with MD demonstrated significantly higher levels of t-tau and p-tau181, and lower levels of A\u03b21\u201342, compared to VaD (p &lt; 0.004 for all analyses). With the exception of p-tau181\/t-tau, all calculated ratios enabled differentiation between these groups. ROC analysis confirmed the high diagnostic accuracy of CSF A\u03b21\u201342 and t-tau (AUC 0.82 and 0.79 respectively) for detecting AD pathology in dementia patients. Furthermore, the t-tau\/A\u03b21\u201342, p-tau181\/A\u03b21\u201342 ratios were the most effective in differentiating AD-related from vascular pathologies (AUC 0.78 and 0.80 respectively), and in differentiating MD from VaD (AUC 0.79 and 0.77 respectively). A significant correlation was observed between CSF biomarkers (especially tau markers) and cognitive impairment severity. Conclusions: CSF biomarkers effectively differentiate mixed from vascular dementia by identifying underlying AD pathology independent of the clinical phenotype. This supports the use of CSF biomarkers in clinical practice to reveal the neurodegenerative component in patients with cerebrovascular disease, which is of fundamental importance for emerging disease-modifying treatment strategies in mixed neuropathologies.<\/jats:p>","DOI":"10.3390\/medicina62050833","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:32:22Z","timestamp":1777469542000},"page":"833","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CSF Amyloid and Tau Biomarkers Distinguish Mixed from Vascular Dementia by Identifying Alzheimer\u2019s Disease Co-Pathology"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1659-8299","authenticated-orcid":false,"given":"Zuzana","family":"Andr\u00e9","sequence":"first","affiliation":[{"name":"2nd Department of Neurology, Faculty of Medicine, Comenius University Bratislava, University Hospital Bratislava, 831 01 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kop\u00e1niov\u00e1","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, Faculty of Medicine, Comenius University Bratislava, University Hospital Bratislava, 831 01 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Ga\u0161tanov\u00e1","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, Faculty of Medicine, Comenius University Bratislava, University Hospital Bratislava, 831 01 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-7557","authenticated-orcid":false,"given":"Petra","family":"Brandoburov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Psychology, Faculty of Arts, Comenius University in Bratislava, 811 02 Bratislava, Slovakia"},{"name":"MEMORY Centre, 851 03 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6578-8091","authenticated-orcid":false,"given":"Veronika","family":"Re\u017en\u00e1kov\u00e1","sequence":"additional","affiliation":[{"name":"MEMORY Centre, 851 03 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fabian","sequence":"additional","affiliation":[{"name":"Department of Magnetic Resonance Imaging, Dr. Magnet Ltd., 831 01 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9895-7076","authenticated-orcid":false,"given":"Pavol","family":"Povinec","sequence":"additional","affiliation":[{"name":"PET\/CT Centre, Biont a.s., 842 29 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-2042","authenticated-orcid":false,"given":"Jozef","family":"Hanes","sequence":"additional","affiliation":[{"name":"Slovak Academy of Sciences, Institute of Neuroimmunology, 841 04 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Gmitterov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Slovak Medical University, University Hospital Bratislava, 821 01 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s Disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","article-title":"Small Vessel Disease: Mechanisms and Clinical Implications","volume":"18","author":"Wardlaw","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/WNL.0000000000007654","article-title":"CNS Small Vessel Disease: A Clinical Review","volume":"92","author":"Cannistraro","year":"2019","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1749-6632.2002.tb04817.x","article-title":"Vascular Basis of Alzheimer\u2019s Pathogenesis","volume":"977","year":"2002","journal-title":"Ann. N. Y Acad. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","article-title":"Brain Infarction and the Clinical Expression of Alzheimer Disease. The Nun Study","volume":"277","author":"Snowdon","year":"1997","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jacc.2025.11.008","article-title":"Vascular Cognitive Impairment and Dementia: Clinical Features, Neuropathology, and Biomarkers","volume":"87","author":"Sachdev","year":"2026","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kim, H.W., Hong, J., and Jeon, J.C. (2020). Cerebral Small Vessel Disease and Alzheimer\u2019s Disease: A Review. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00927"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e13061","DOI":"10.1111\/bpa.13061","article-title":"Pathological Changes within the Cerebral Vasculature in Alzheimer\u2019s Disease: New Perspectives","volume":"32","author":"Fisher","year":"2022","journal-title":"Brain Pathol."},{"key":"ref_9","first-page":"1","article-title":"Vascular Risk Factors and Alzheimer\u2019s Disease: Are These Risk Factors for Plaques and Tangles or for Concomitant Vascular Pathology That Increases the Likelihood of Dementia? An Evidence-Based Review","volume":"4","author":"Chui","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","article-title":"Practice Parameter: Diagnosis of Dementia (an Evidence-Based Review). Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"56","author":"Knopman","year":"2001","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The Diagnosis of Dementia Due to Alzheimer\u2019s Disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association Workgroups on Diagnostic Guidelines for Alzheimer\u2019s Disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing Research Diagnostic Criteria for Alzheimer\u2019s Disease: The IWG-2 Criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised Criteria for Diagnosis and Staging of Alzheimer\u2019s Disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/WNL.0b013e318221acee","article-title":"Identification of Pure Subcortical Vascular Dementia Using 11C-Pittsburgh Compound B","volume":"77","author":"Lee","year":"2011","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal Fluid Biomarker Signature in Alzheimer\u2019s Disease Neuroimaging Initiative Subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archpsyc.61.1.95","article-title":"Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosis of Alzheimer Disease: A Comparative Cerebrospinal Fluid Study","volume":"61","author":"Hampel","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1007\/s00415-013-7047-3","article-title":"Cerebrospinal Fluid Biomarkers in Alzheimer\u2019s Disease, Vascular Dementia and Ischemic Stroke Patients: A Critical Analysis","volume":"260","author":"Kaerst","year":"2013","journal-title":"J. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31823ed0f0","article-title":"Cerebrospinal Fluid Markers for Differential Dementia Diagnosis in a Large Memory Clinic Cohort","volume":"78","author":"Schoonenboom","year":"2012","journal-title":"Neurology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular Dementia: Diagnostic Criteria for Research Studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Tatemichi","year":"1993","journal-title":"Neurology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging Standards for Research into Small Vessel Disease and Its Contribution to Ageing and Neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jalz.2016.10.007","article-title":"The Vascular Impairment of Cognition Classification Consensus Study","volume":"13","author":"Skrobot","year":"2017","journal-title":"Alzheimers Dement."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A Conceptual Framework for Research on Subjective Cognitive Decline in Preclinical Alzheimer\u2019s Disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A Consensus Protocol for the Standardization of Cerebrospinal Fluid Collection and Biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR Signal Abnormalities at 1.5 T in Alzheimer\u2019s Dementia and Normal Aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","article-title":"Neuroimaging Standards for Research into Small Vessel Disease-Advances since 2013","volume":"22","author":"Duering","year":"2023","journal-title":"Lancet Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/jgs.18124","article-title":"Conversion between the Montreal Cognitive Assessment and the Mini-Mental Status Examination","volume":"71","author":"Fasnacht","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1161\/STR.0000000000000494","article-title":"Vascular Contributions to Cognitive Impairment and Dementia in the United States: Prevalence and Incidence: A Scientific Statement from the American Heart Association","volume":"56","author":"Smith","year":"2025","journal-title":"Stroke"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Llorens, F., Schmitz, M., Knipper, T., Schmidt, C., Lange, P., Fischer, A., Hermann, P., and Zerr, I. (2017). Cerebrospinal Fluid Biomarkers of Alzheimer\u2019s Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia. Front. Aging Neurosci., 9.","DOI":"10.3389\/fnagi.2017.00289"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3233\/JAD-190651","article-title":"Characteristic Biomarker and Cognitive Profile in Incipient Mixed Dementia","volume":"73","author":"Molinder","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/brain\/awv181","article-title":"Cerebrospinal Fluid Tau and Amyloid-\u03921-42 in Patients with Dementia","volume":"138","author":"Farahmand","year":"2015","journal-title":"Brain"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Tsantzali, I., Athanasaki, A., Boufidou, F., Constantinides, V.C., Stefanou, M.-I., Moschovos, C., Zompola, C., Paraskevas, S.G., Bonakis, A., and Giannopoulos, S. (2024). Cerebrospinal Fluid Classical Biomarker Levels in Mixed vs. Pure A+T+ (A+T1+) Alzheimer\u2019s Disease. Biomedicines, 12.","DOI":"10.3390\/biomedicines12122904"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/NEN.0000000000000157","article-title":"Tau Proteins in the Temporal and Frontal Cortices in Patients with Vascular Dementia","volume":"74","author":"Mugica","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archneur.59.8.1267","article-title":"Differential Diagnosis of Alzheimer Disease with Cerebrospinal Fluid Levels of Tau Protein Phosphorylated at Threonine 231","volume":"59","author":"Buerger","year":"2002","journal-title":"Arch. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(00)01697-9","article-title":"Transient Increase in Total Tau but Not Phospho-Tau in Human Cerebrospinal Fluid after Acute Stroke","volume":"297","author":"Hesse","year":"2001","journal-title":"Neurosci. Lett."},{"key":"ref_35","first-page":"e1137","article-title":"Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration","volume":"98","author":"Grinberg","year":"2022","journal-title":"Neurology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3233\/JAD-210144","article-title":"Heterogeneity of Cerebrospinal Fluid Biomarkers Profiles in Individuals with Distinct Levels of Cognitive Decline: A Cross-Sectional Study","volume":"81","author":"Pais","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/jamaneurol.2025.0693","article-title":"Cerebrospinal Fluid Biomarkers for Alzheimer Disease Among Patients With Dementia","volume":"82","author":"Skoog","year":"2025","journal-title":"JAMA Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/10408363.2019.1670613","article-title":"Cerebrospinal Fluid Proteomics and Biological Heterogeneity in Alzheimer\u2019s Disease: A Literature Review","volume":"57","author":"Wesenhagen","year":"2020","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jns.2012.08.003","article-title":"The Role of CSF Biomarkers in the Diagnostic Work-up of Mixed Vascular-Degenerative Dementia","volume":"322","author":"Engelborghs","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3233\/JAD-230680","article-title":"Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-\u03b2 Protein Precursor \u03b2 in the Subcortical Small Vessel Type of Dementia","volume":"96","author":"Kettunen","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/cdd.2014.68","article-title":"Lipocalin 2 Modulates the Cellular Response to Amyloid Beta","volume":"21","author":"Mesquita","year":"2014","journal-title":"Cell Death Differ."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101984","DOI":"10.1016\/j.arr.2023.101984","article-title":"Association between Lipocalin-2 and Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis of Population-Based Evidence","volume":"89","author":"Li","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e213676","DOI":"10.1212\/WNL.0000000000213676","article-title":"Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease","volume":"104","author":"Kirsebom","year":"2025","journal-title":"Neurology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-160722","article-title":"Cerebrospinal Fluid A\u03b242\/40 Corresponds Better than A\u03b242 to Amyloid PET in Alzheimer\u2019s Disease","volume":"55","author":"Lewczuk","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-220673","article-title":"A Review of Application of A\u03b242\/40 Ratio in Diagnosis and Prognosis of Alzheimer\u2019s Disease","volume":"90","author":"Xu","year":"2022","journal-title":"J. Alzheimers Dis."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/833\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:11:27Z","timestamp":1779689487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["medicina62050833"],"URL":"https:\/\/doi.org\/10.3390\/medicina62050833","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}